ELMYBUS Trademark

Trademark Overview

On Friday, February 23, 2024, a trademark application was filed for ELMYBUS with the United States Patent and Trademark Office. The USPTO has given the ELMYBUS trademark a serial number of 98418843. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, September 25, 2025. This trademark is owned by LABORATOIRES THEA. The ELMYBUS trademark is filed in the Pharmaceutical Products category with the following description:

Anti-glaucoma preparations for ophthalmic use
elmybus

General Information

Serial Number98418843
Word MarkELMYBUS
Filing DateFriday, February 23, 2024
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, September 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 6, 2024

Trademark Statements

Goods and ServicesAnti-glaucoma preparations for ophthalmic use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 23, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLABORATOIRES THEA
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCLERMONT-FERRAND 63100
FR
Party NameLABORATOIRES THEA
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCLERMONT-FERRAND 63100
FR

Trademark Events

Event DateEvent Description
Friday, February 23, 2024NEW APPLICATION ENTERED
Friday, February 23, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 24, 2024ASSIGNED TO EXAMINER
Thursday, April 11, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 11, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, April 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 11, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 27, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 6, 2024PUBLISHED FOR OPPOSITION
Wednesday, March 19, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 19, 2025TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Wednesday, March 19, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 6, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 1, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 19, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 19, 2025SOU TEAS EXTENSION RECEIVED
Thursday, March 20, 2025SOU EXTENSION 1 GRANTED
Thursday, March 20, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 19, 2025SOU EXTENSION 1 FILED
Thursday, September 25, 2025SOU EXTENSION 2 FILED
Thursday, September 25, 2025SOU TEAS EXTENSION RECEIVED
Thursday, September 25, 2025SOU EXTENSION 2 GRANTED
Thursday, September 25, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

elmybus ophthalmic preparations glaucoma anti